I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study

✍ Scribed by Bobrie, Guillaume

• Book ID: 119218621
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 592 KB
• Volume: 34
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2012.07.001